Blue Trust Inc’s Mesoblast MESO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,002
Closed -$13.6K – 2689
2026
Q2
$13.6K Hold
1,002
– – ﹤0.01% 1774
2026
Q1
$15.4K Buy
+1,002
New +$16.7K ﹤0.01% 1719
2024
Q4
– Sell
-146
Closed -$994 – 2762
2024
Q3
$994 Buy
146
+101
+224% +$686 ﹤0.01% 2700
2024
Q2
$225 Buy
+45
New +$308 ﹤0.01% 2660
2024
Q1
– Sell
-582
Closed -$1K – 2513
2023
Q4
$1K Buy
+582
New +$1.39K ﹤0.01% 2361
2023
Q3
– Sell
-8
Closed – – 2191
2023
Q2
$0 Sell
8
-123
-94% -$879 ﹤0.01% 2328
2023
Q1
$1K Sell
131
-397
-75% -$2.63K ﹤0.01% 2174
2022
Q4
$3K Buy
528
+128
+32% +$800 ﹤0.01% 1855
2022
Q3
$2K Buy
+400
New +$2.42K ﹤0.01% 1802

Other funds holding MESO

Blue Trust Inc's MESO Position: Q3 2026 in Review

Blue Trust Inc sold out of Mesoblast (MESO) in Q3 2026, closing a stake of 1,002 shares — an estimated $13.6K sold.

Blue Trust Inc first reported a position in MESO in Q3 2022 and held it in 9 quarters. The position peaked at $15.4K in Q1 2026. 30 funds tracked by Wall St. Rank hold MESO as of Q3 2026.

  • Blue Trust Inc reported no remaining Mesoblast position as of Q3 2026 after selling out during the quarter.
  • Blue Trust Inc sold 1,002 Mesoblast shares in Q3 2026, an estimated $13.6K.
  • Blue Trust Inc first reported a position in Mesoblast in Q3 2022 and held it in 9 quarters.
  • Blue Trust Inc's Mesoblast position peaked at $15.4K in Q1 2026.
  • 30 funds tracked by Wall St. Rank held Mesoblast as of Q3 2026.

Based on Blue Trust Inc's 13F filing for Q3 2026, filed 15 Oct 2026.